Stockholders' Equity	9 Months Ended
Sep. 30, 2018
Equity [Abstract]
Stockholders' Equity	9. Stockholders’ Equity *Stock Options* - During the nine months ended September 30, 2018, the Company issued an aggregate of 405,000 options to purchase the Company’s common stock at between $1.30 and $1.55 per share with a term of five years to employees at its technology, corporate and printed products divisions, as well as independent board members. The options granted during the three months ended June 30, 2018 vest pro-ratably as follows: 1/3 on the grant date, 1/3 on the first anniversary of the grant date and 1/3 on the second anniversary of the grant date as long as the employee is employed or direct is active on such dates. The options granted during the three months ended September 30, 2018 vest pro-ratably as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date. The options had an aggregate estimated fair value on the grant date of approximately $335,000 using the Black-Scholes-Merton option pricing model with a volatility of 98.1% - 98.2%, a risk-free rate of return of 2.67% - 2.96% and zero dividend and forfeiture estimates. *Sales of Equity* - On August 30, 2017, the Company sold 1,200,000 shares of unregistered common stock and five-year warrants to purchase up to an aggregate of 240,000 additional shares of the Company’s common stock at an exercise price of $1.00 to a total of two related party accredited investors for an aggregate purchase price of $900,000, of which $300,000 was recorded as a subscription receivable as of December 31, 2017 in the stockholders equity section. On March 29, 2018, the Company received the payment of the $300,000 subscription receivable from the investor, which is presented net of $12,000 of financing costs. On July 3, 2018, the Company sold 214,286 shares of its common stock, par value $0.02 per share, to a related party accredited investor, Heng Fai Holdings Limited. The purchase price was $1.40 per share, for total proceeds of $300,000. *Stock-Based Payments and Compensation -* The Company records stock-based payment expense related to options and warrants based on the grant date fair value in accordance with FASB ASC 718. Stock-based compensation includes expense charges for all stock-based awards to employees, directors and consultants. Such awards include option grants, warrant grants, and restricted stock awards. During the nine months ended September 30, 2018, the Company had stock compensation expense of approximately $107,000 or less than $0.01 basic and diluted earnings per share ($203,000; $0.01 basic and diluted earnings per share for the corresponding nine months ended September 30, 2017).

Stockholders' Equity

9 Months Ended

Sep. 30, 2018

9. Stockholders’ Equity

Stock Options - During the nine months ended September 30, 2018, the Company issued an aggregate of 405,000 options to purchase the Company’s common stock at between $1.30 and $1.55 per share with a term of five years to employees at its technology, corporate and printed products divisions, as well as independent board members. The options granted during the three months ended June 30, 2018 vest pro-ratably as follows: 1/3 on the grant date, 1/3 on the first anniversary of the grant date and 1/3 on the second anniversary of the grant date as long as the employee is employed or direct is active on such dates. The options granted during the three months ended September 30, 2018 vest pro-ratably as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date. The options had an aggregate estimated fair value on the grant date of approximately $335,000 using the Black-Scholes-Merton option pricing model with a volatility of 98.1% - 98.2%, a risk-free rate of return of 2.67% - 2.96% and zero dividend and forfeiture estimates.

Sales of Equity - On August 30, 2017, the Company sold 1,200,000 shares of unregistered common stock and five-year warrants to purchase up to an aggregate of 240,000 additional shares of the Company’s common stock at an exercise price of $1.00 to a total of two related party accredited investors for an aggregate purchase price of $900,000, of which $300,000 was recorded as a subscription receivable as of December 31, 2017 in the stockholders equity section. On March 29, 2018, the Company received the payment of the $300,000 subscription receivable from the investor, which is presented net of $12,000 of financing costs.

On July 3, 2018, the Company sold 214,286 shares of its common stock, par value $0.02 per share, to a related party accredited investor, Heng Fai Holdings Limited. The purchase price was $1.40 per share, for total proceeds of $300,000.

Stock-Based Payments and Compensation - The Company records stock-based payment expense related to options and warrants based on the grant date fair value in accordance with FASB ASC 718. Stock-based compensation includes expense charges for all stock-based awards to employees, directors and consultants. Such awards include option grants, warrant grants, and restricted stock awards. During the nine months ended September 30, 2018, the Company had stock compensation expense of approximately $107,000 or less than $0.01 basic and diluted earnings per share ($203,000; $0.01 basic and diluted earnings per share for the corresponding nine months ended September 30, 2017).